Top Markets
#1 Siren Siren +39.19%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.65%
#3 Ocean Protocol Ocean Protocol +15.51%
#4 KUB Coin KUB Coin +15.08%
#5 Perle Perle +11.39%
#6 Audiera Audiera +11.03%
#7 Geodnet Geodnet +9.30%
#8 Nockchain Nockchain +9.22%
#9 Arowana Arowana +8.26%
#10 Wiki Cat Wiki Cat +8.24%
Coin of the day
Siren Siren
設定
言語
日本
通貨
USD
テーマ
Antibe Therapeutics Inc. Antibe Therapeutics Inc.

Antibe Therapeutics Inc.

ATE
株式のランク #32097
Antibe Therapeutics Inc. is a biotechnology company specializing in the... Antibe Therapeutics Inc. is a biotechnology company specializing in the development of groundbreaking therapeutics and medical devices. Operating internationally, including Canada, Europe, and the United States, their work targets pain, inflammation, and regenerative medicine. A key focus is developing drugs designed to prevent the gastrointestinal harm and bleeding often caused by non-steroidal anti-inflammatory drugs. Their leading candidate, Otenaproxesul, is a hydrogen sulfide-releasing derivative of naproxen. This compound has already finished a Phase 2B gastrointestinal safety study and is being investigated for a range of indications, such as post-operative pain, migraines, dysmenorrhea, traumatic injuries, dental pain, and gout. Additionally, their product portfolio features ATB-352, currently in preclinical development for managing acute pain. The company, incorporated in 2009, is headquartered in Toronto, Canada.
株価
$0.21483059
最終同期: 2024-05-07
時価総額
$11.13M
変化（1日）
0.34%
変化（1年）
0.00%
国
CA
取引 Antibe Therapeutics Inc. (ATE)

カテゴリー

Healthcare
Antibe Therapeutics Inc.（ATE）の配当履歴
Antibe Therapeutics Inc.（証券コード：ATE）は合計で0回の配当を行いました。
すべての配当の合計（株式分割調整済み）は：0.00
配当利回り（TTM）：0
2026から2026までのAntibe Therapeutics Inc.（ATE）の配当履歴
年間配当支払い
年 配当（株式分割調整済み） 変化
提供された日付のデータは十分ではありません。
すべての配当支払いの一覧
年 配当 変化
提供された日付のデータは十分ではありません。
同業他社や競合企業の配当履歴
企業 配当支払い回数 国
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US